Analysts' recommendations: Carmat SA

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
10/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat SA

05/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris Other stock markets 03:55:00 20/03/26 am AEDT			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

Market Cap	6.15M 7.03M 5.67M 5.24M 9.93M 670M 10.1M 67.73M 26.6M 330M 26.38M 25.81M 1.13B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 67.73M 54.65M 50.47M 95.77M 6.46B 97.38M 653M 256M 3.18B 254M 249M 10.94B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
07/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
07/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
05/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
16/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE
01/10/25	Carmat: Judiciary administrator has submitted request to convert receivership into liquidation to court	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
05/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Current year	0.1	0.1
1 year	0.08	0.59
3 years	0.08	9.99
5 years	0.08	31.7
10 years	0.08	44.95

Carmat SA Stock

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat SA

Chart: Carmat SA

Latest news : Carmat SA

Analysts' recommendations: Carmat SA

Press Releases: Carmat SA

News in other languages: Carmat SA

Course Extremes

Managers and Directors: Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
13/03/25	Pierre Bastid	Buy	Chairman	1,343,333	2.3347%
13/03/25	Pierre Bastid	Sell	Chairman	1,343,333	2.3347%
29/05/24	Antonino Ligresti	Buy	Director	1,343,333	4.6122%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-70.80%	-98.71%	7.08M
STRYKER CORPORATION	+0.82%	+0.99%	-16.46%	+11.68%	126B
SMITH & NEPHEW PLC	+0.84%	+1.15%	-1.34%	-2.61%	12.9B
GLAUKOS CORPORATION	-1.52%	+2.95%	+43.33%	+115.86%	8.97B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.14%	-2.38%	-47.99%	-72.05%	3.98B
DOUBLE MEDICAL TECHNOLOGY INC.	-0.47%	-1.34%	+22.30%	+45.04%	2.7B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.61%	-7.70%	-14.72%	-20.20%	1.74B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.49%	-3.87%	-4.88%	-25.01%	1.61B
INSPIRE MEDICAL SYSTEMS, INC.	+0.47%	+10.24%	-62.83%	-83.35%	1.49B
Average	+0.60%	+0.13%	-17.04%	-14.37%	17.76B
Weighted average by Cap.	+0.74%	+1.01%	-12.32%	+13.24%

	2023	2024
Net sales	3.84M 4.39M 3.54M 3.27M 6.2M 418M 6.31M 42.29M 16.61M 206M 16.47M 16.11M 709M	7.34M 8.4M 6.77M 6.26M 11.87M 801M 12.07M 80.94M 31.78M 394M 31.52M 30.84M 1.36B
Net income	-53.87M -61.59M -49.69M -45.89M -87.08M -5.87B -88.54M -594M -233M -2.89B -231M -226M -9.95B	-51.4M -58.76M -47.41M -43.78M -83.08M -5.6B -84.48M -566M -222M -2.76B -221M -216M -9.49B
Net Debt	49.64M 56.75M 45.78M 42.29M 80.23M 5.41B 81.58M 547M 215M 2.67B 213M 208M 9.17B	53.1M 60.71M 48.98M 45.24M 85.83M 5.79B 87.28M 585M 230M 2.85B 228M 223M 9.81B